EXEL

Exelixis (EXEL)

About Exelixis (EXEL)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Details

Daily high

$44.20

Daily low

$42.75

Price at open

$42.86

52 Week High

$49.62

52 Week Low

$32.38

Market cap

11.8B

Dividend yield

0.00%

Volume

3.4M

Avg. volume

2.6M

P/E ratio

18.48

Exelixis News